Scientific Presentations

Filter:

Recent 2023 2022 2021 2020
2019 2018 2017 2016 2014
2013 2012 2011 2010
Home OCT & Notal OCT Analyzer
ForeseeHome
ARVO 2023 | April 2023

Predictive Value of Preferential Hyperacuity Perimetry in Identifying Patients at High Risk of Conversion to Neovascular AMD

Emily Chew, MD
ARVO 2023 | April 2023

A Tele-Ophthalmology Model for Remote Monitoring of Patients with Age-Related Macular Degeneration

Jennifer Jacobs, MD

View the poster presentation here

Hawaiian Eye and Retina Meeting 2023 | January 2023

Update on Home Monitoring of AMD

Judy E. Kim, MD
Virtual Retina Case Conference Canada (RCCC) 2022 | December 2022

Real World Wins for Artificial Intelligence: Preventing AMD Vision Loss

Anat Loewenstein, MD
THE RETINA SOCIETY 55TH ANNUAL SCIENTIFIC MEETING | November 2022

The ALOFT Study

Allen Ho, MD

Poster

FDA Intended Use

ForeseeHome has not been approved by FDA for use other than described in the following Indication for Use: The ForeseeHome is intended for use in the detection and characterization of central and paracentral metamorphopsia (visual distortion) in patients with age-related macular degeneration as an aid in monitoring progression of disease factors causing metamorphopsia including, but not limited to choroidal neovascularization (CNV). It is intended to be used at home for patients with stable fixation.

Media enquiries? Reach out to our Media Contact